tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Gliosis D005911 6 associated lipids
Kidney Tubular Necrosis, Acute D007683 3 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Hallucinations D006212 4 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Rosacea D012393 13 associated lipids
Pericarditis D010493 6 associated lipids
Hyperpigmentation D017495 11 associated lipids
Autonomic Nervous System Diseases D001342 4 associated lipids
Psychoses, Substance-Induced D011605 7 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Long QT Syndrome D008133 10 associated lipids
Intestinal Pseudo-Obstruction D007418 5 associated lipids
Mycoses D009181 18 associated lipids
Liver Failure D017093 5 associated lipids
Epilepsy, Temporal Lobe D004833 4 associated lipids
Retinoblastoma D012175 12 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Gastroenteritis D005759 4 associated lipids
Hypertrophy, Left Ventricular D017379 12 associated lipids
Inappropriate ADH Syndrome D007177 4 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Pityriasis D010915 3 associated lipids
Hand Dermatoses D006229 5 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Liver Abscess D008100 6 associated lipids
Carpal Tunnel Syndrome D002349 3 associated lipids
Foot Dermatoses D005533 3 associated lipids
Anus Diseases D001004 3 associated lipids
Endomyocardial Fibrosis D004719 4 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Herpesviridae Infections D006566 4 associated lipids
Leukoencephalopathies D056784 3 associated lipids
Pouchitis D019449 3 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Epstein-Barr Virus Infections D020031 3 associated lipids
Labyrinthitis D007762 2 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Dementia, Vascular D015140 7 associated lipids
Mastocytosis D008415 5 associated lipids
Molluscum Contagiosum D008976 2 associated lipids
Paresis D010291 2 associated lipids
Intracranial Hypertension D019586 4 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Chronic Disease D002908 7 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Vitiligo D014820 2 associated lipids
Hemophilia B D002836 3 associated lipids
Myasthenia Gravis D009157 5 associated lipids
Hyperkalemia D006947 3 associated lipids
Intracranial Thrombosis D020767 2 associated lipids
Pemphigus, Benign Familial D016506 3 associated lipids
Skin Diseases, Vesiculobullous D012872 5 associated lipids
Prurigo D011536 4 associated lipids
Hepatitis, Viral, Animal D006524 4 associated lipids
Cryptococcosis D003453 3 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Simian Acquired Immunodeficiency Syndrome D016097 4 associated lipids
Castleman Disease D005871 3 associated lipids
Wounds, Stab D014951 3 associated lipids
Keratosis, Actinic D055623 3 associated lipids
Toxocariasis D014120 3 associated lipids
Fistula D005402 8 associated lipids
Confusion D003221 4 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Uveitis, Anterior D014606 11 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Viremia D014766 4 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Parotitis D010309 4 associated lipids
Tuberous Sclerosis D014402 2 associated lipids
Ocular Motility Disorders D015835 2 associated lipids
Pain, Intractable D010148 4 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Perceptual Disorders D010468 3 associated lipids
Polyneuropathies D011115 3 associated lipids
Heart Injuries D006335 6 associated lipids
Hearing Loss, Noise-Induced D006317 4 associated lipids
Exanthema D005076 11 associated lipids
Bronchiolitis D001988 6 associated lipids
Reflex Sympathetic Dystrophy D012019 4 associated lipids
Kartagener Syndrome D007619 2 associated lipids
Earache D004433 2 associated lipids
Delayed Graft Function D051799 2 associated lipids
Gingival Hyperplasia D005885 3 associated lipids
Intussusception D007443 1 associated lipids
Neoplasms, Second Primary D016609 4 associated lipids
Paraparesis, Tropical Spastic D015493 1 associated lipids
Crigler-Najjar Syndrome D003414 1 associated lipids
Apraxias D001072 1 associated lipids
Cholangitis, Sclerosing D015209 1 associated lipids
Venous Insufficiency D014689 2 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Brazis PW et al. A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. 2000 Am. J. Ophthalmol. pmid:10764869
Gordjani N et al. Cyclosporin-A-induced effects on the free Ca2+ concentration in LLC-PK1-cells and their mechanisms. 2000 Pflugers Arch. pmid:10764223
Nevins TE Overview of new immunosuppressive therapies. 2000 Curr. Opin. Pediatr. pmid:10763765
Thorp M et al. The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. 2000 Transplantation pmid:10762229
Tchah H and Lim B Effect of FK 506 on the cornea: use of topical FK 506 in corneal transplantation in a guinea pig-rat model. 1999 Korean J Ophthalmol pmid:10761401
Minervini MI et al. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). 2000 Am. J. Surg. Pathol. pmid:10757402
Yamamoto K et al. Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice. 2000 Hum. Gene Ther. pmid:10757347
Takahashi N [Macrolide compounds as inhibitors of the intracellular signal transmission pathway: the mechanism of actions of rapamycin and FK506]. 2000 Jpn J Antibiot pmid:10756454
Kano S et al. [Role of FK506-binding protein (FKBP) in Ca+ oscillation in bronchial epithelial cells]. 2000 Jpn J Antibiot pmid:10756444
Mohamed MA et al. TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus. 2000 Transplantation pmid:10755567
Miller J et al. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. 2000 Transplantation pmid:10755543
Johnson C et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. 2000 Transplantation pmid:10755536
Harmon JD et al. Stuttering priapism in a liver transplant patient with toxic levels of fk506. 1999 Urology pmid:10754131
Freeman EE and Grosskreutz CL The effects of FK506 on retinal ganglion cells after optic nerve crush. 2000 Invest. Ophthalmol. Vis. Sci. pmid:10752948
Davis DL et al. Biochemical characterization of the minor immunophilins. 2000 Clin. Biochem. pmid:10751584
Wang MS and Gold BG FK506 increases the regeneration of spinal cord axons in a predegenerated peripheral nerve autograft. 1999 J Spinal Cord Med pmid:10751133
Shimizu T et al. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts. 1999 Clin Transplant pmid:10751057
Chiou WL et al. Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice. 2000 Pharm. Res. pmid:10751036
Minematsu T et al. Pharmacokinetic/pharmacodynamic analysis of tacrolimus-induced QT prolongation in guinea pigs. 1999 Biol. Pharm. Bull. pmid:10746167
Gaziev D et al. Chronic graft-versus-host disease: is there an alternative to the conventional treatment? 2000 Bone Marrow Transplant. pmid:10745252
Skuk D et al. Myoblast transplantation in whole muscle of nonhuman primates. 2000 J. Neuropathol. Exp. Neurol. pmid:10744058
Emre S et al. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. 2000 Transpl. Int. pmid:10743694
Yoshida EM et al. Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series. 2000 Transpl. Int. pmid:10743693
Weidelt T and Isenberg G Augmentation of SR Ca(2+) release by rapamycin and FK506 causes K(+)-channel activation and membrane hyperpolarization in bladder smooth muscle. 2000 Br. J. Pharmacol. pmid:10742283
Dubowchik GM et al. Fluoresceinated FKBP12 ligands for a high-throughput fluorescence polarization assay. 2000 Bioorg. Med. Chem. Lett. pmid:10741553
Li ST et al. High Ca(2+)/low Mg(2+) solution induces long-term depression in rat CA1 pyramidal neurons. 2000 Neurosci. Lett. pmid:10739895
Böhmig GA et al. Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft. 2000 Am. J. Kidney Dis. pmid:10739788
Wong KM et al. Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients. 2000 Am. J. Kidney Dis. pmid:10739787
Kawai T et al. FK506-induced autoimmune diabetes. 2000 Ann. Intern. Med. pmid:10733461
Adalsteinsson H and Bruice TC Generation and evaluation of putative neuroregenerative drugs. Part 1: virtual point mutations to the polyketide rapamycin. 2000 Bioorg. Med. Chem. pmid:10732978
Prima V et al. Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds. 2000 Jan-Feb J. Steroid Biochem. Mol. Biol. pmid:10731632
Squadrito F et al. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia- reperfusion injury. 2000 J. Mol. Cell. Cardiol. pmid:10731442
Eades SK et al. Increased tacrolimus levels in a pediatric renal transplant patient attributed to chronic diarrhea. 2000 Pediatr Transplant pmid:10731062
Pappas PA et al. Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy. 2000 Pediatr Transplant pmid:10731058
Sigalet DL et al. Impact of FK506 and steroids on adaptation after intestinal resection or segmental transplantation. 2000 Pediatr Transplant pmid:10731053
Ierardi E et al. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum. 2000 J. Clin. Gastroenterol. pmid:10730928
Bargalló N et al. Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy. 2000 AJNR Am J Neuroradiol pmid:10730638
Plosker GL and Foster RH Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. 2000 Drugs pmid:10730553
Fukuda H et al. Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin A. 2000 Int. J. Hematol. pmid:10729997
Konrad T et al. Evidence for impaired glucose effectiveness in cirrhotic patients after liver transplantation. 2000 Metab. Clin. Exp. pmid:10726916
Inomata Y et al. [Weaning of immunosuppression in living-related liver transplantation]. 1999 Nihon Rinsho Meneki Gakkai Kaishi pmid:10726480
Hale GA et al. Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis. 2000 Bone Marrow Transplant. pmid:10723590
Carr DB et al. Maternal hemodynamics and pregnancy outcome in women with prior orthotopic liver transplantation. 2000 Liver Transpl. pmid:10719023
Lee M et al. FK506 promotes functional recovery in crushed rat sciatic nerve. 2000 Muscle Nerve pmid:10716776
Smythe GM et al. Enhanced migration and fusion of donor myoblasts in dystrophic and normal host muscle. 2000 Muscle Nerve pmid:10716768
Campbell G et al. Spontaneous axonal regeneration after optic nerve injury in adult rat. 1999 Neuroreport pmid:10716240
Sugawara T et al. Immunosuppressants promote adult dorsal root regeneration into the spinal cord. 1999 Neuroreport pmid:10716239
Dunnett SB The failure of axon regeneration in the CNS is not absolute. 1999 Neuroreport pmid:10716198
Vela CG et al. Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients. 2000 Transplant. Proc. pmid:10715453
Morita H et al. Acceptance of skin xenografts (from guinea pig to mice) by portal venous and intravenous injections of donor hematolymphoid cells. 2000 Transplant. Proc. pmid:10715422
Takada Y et al. Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. 2000 Transplant. Proc. pmid:10715416
Mamane Y et al. Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52. 2000 Immunity pmid:10714679
Egner R et al. The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility. 2000 Mol. Microbiol. pmid:10712705
DuBell WH et al. K(+) currents responsible for repolarization in mouse ventricle and their modulation by FK-506 and rapamycin. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10710358
Kitabayashi H et al. FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. 2000 J. Cardiovasc. Pharmacol. pmid:10710126
Kuriyama S et al. Immunomodulation with FK506 around the time of intravenous re-administration of an adenoviral vector facilitates gene transfer into primed rat liver. 2000 Int. J. Cancer pmid:10709105
Singh N et al. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. 2000 Transplantation pmid:10708096
Lapa e Silva JR et al. Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus. 1999 Mediators Inflamm. pmid:10704085
James JA et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. 2000 J. Clin. Periodontol. pmid:10703661
Bartucci MR Issues in cyclosporine drug substitution: implications for patient management. 1999 J Transpl Coord pmid:10703396
Ulsh PJ et al. New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation. 1999 J Transpl Coord pmid:10703393
Soran A et al. Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients. 1999 J Transpl Coord pmid:10703390
Dumont FJ FK506, an immunosuppressant targeting calcineurin function. 2000 Curr. Med. Chem. pmid:10702636
Rovira P et al. The impact of immunosuppressive drugs on the analysis of T cell activation. 2000 Curr. Med. Chem. pmid:10702633
Migita K et al. FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts. 2000 Lab. Invest. pmid:10701683
Williams ST et al. Preliminary analysis of a randomized trial comparing microemulsion cyclosporine and tacrolimus for recipients of renal transplants from non-heart-beating donors. 2000 Transplant. Proc. pmid:10701022
White SA et al. Influence of delayed graft function in renal transplants from cadaveric or non-heart-beating donors. 2000 Transplant. Proc. pmid:10701018
Braun F et al. Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression. 2000 Transplant. Proc. pmid:10700989
White SA et al. Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients. 2000 Transplant. Proc. pmid:10700949
Aronowski J et al. Interplay between the gamma isoform of PKC and calcineurin in regulation of vulnerability to focal cerebral ischemia. 2000 J. Cereb. Blood Flow Metab. pmid:10698072
Bader A et al. Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions. 2000 Br. J. Pharmacol. pmid:10694240
Davis DL et al. Minor immunophilin binding of tacrolimus and sirolimus metabolites. 2000 Clin. Biochem. pmid:10693980
LaPres JJ et al. ARA9 modifies agonist signaling through an increase in cytosolic aryl hydrocarbon receptor. 2000 J. Biol. Chem. pmid:10692406
Suga Y et al. A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus. 2000 J. Am. Acad. Dermatol. pmid:10688732
Glynne R et al. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. 2000 Nature pmid:10688206
Oppenheimer F Steroid withdrawal in renal transplant recipients. 2000 Transplant. Proc. pmid:10686314
Li XC and Strom TB Blocking T-cell costimulation in transplantation: opportunities and challenges. 2000 Transfusion pmid:10685997
Sengoku T et al. FK506 inhibition of histamine release and cytokine production by mast cells and basophils. 2000 Int. J. Immunopharmacol. pmid:10685002
Filler G et al. Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression. 2000 Pediatr. Nephrol. pmid:10684356
Del Poeta M et al. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. 2000 Antimicrob. Agents Chemother. pmid:10681348
Skuk D and Tremblay JP Progress in myoblast transplantation: a potential treatment of dystrophies. 2000 Feb 1-15 Microsc. Res. Tech. pmid:10679968
Tisdale JF et al. Cyclophosphamide and other new agents for the treatment of severe aplastic anemia. 2000 Semin. Hematol. pmid:10676915
de Mattos AM et al. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. 2000 Am. J. Kidney Dis. pmid:10676738
Misawa A et al. FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. 2000 Bone Marrow Transplant. pmid:10673708
Sayo Y et al. Transforming growth factor beta induction of insulin gene expression is mediated by pancreatic and duodenal homeobox gene-1 in rat insulinoma cells. 2000 Eur. J. Biochem. pmid:10672004
Hirose R et al. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. 2000 Transplantation pmid:10670644
Jordan ML et al. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. 2000 Transplantation pmid:10670637
Furukawa H et al. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. 2000 Transplantation pmid:10670633
Winter C et al. The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle. 2000 Neuroscience pmid:10670442
Tyagi MG and Thomas M Enhanced cardiovascular reactivity to desmopressin in water-restricted rats: facilitatory role of immunosuppression. 1999 Methods Find Exp Clin Pharmacol pmid:10669908
Chenhsu RY et al. Renal allograft dysfunction associated with rifampin-tacrolimus interaction. 2000 Ann Pharmacother pmid:10669182
McAlister VC et al. Sirolimus-tacrolimus combination immunosuppression. 2000 Lancet pmid:10665560
Schuppe H et al. Topical tacrolimus for recalcitrant leg ulcer in rheumatoid arthritis. 2000 Rheumatology (Oxford) pmid:10662882
Tamura A et al. Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. 2000 Surgery pmid:10660758
Tamura J et al. [The role of protein kinases and phosphatases in erythroid colony formation of elderly]. 1999 Nihon Ronen Igakkai Zasshi pmid:10655734
Novelli M et al. Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel. 1999 Transpl. Int. pmid:10654359
Wu GS et al. Deoxyspergualin delays xenograft rejection in the guinea pig-to-C6-deficient rat heart transplantation model. 1999 Transpl. Int. pmid:10654352
Jain A et al. Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. 2000 Transplantation pmid:10653398
Reddy KS et al. Simultaneous kidney-pancreas transplantation without antilymphocyte induction. 2000 Transplantation pmid:10653379
Schrama YC et al. Concealed by veils. 2000 Nephrol. Dial. Transplant. pmid:10648679